https://www.marketscreener.com/quote/stock/ATEA-PHARMACEUTICALS-INC-114338425/news/Atea-Pharmaceuticals-Introduces-New-Strategic-Clinical-Development-Program-for-AT-527-in-Covid-19-37328518/?utm_source=telegram&utm_medium=social&utm_campaign=share